Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:ALGN
- CUSIP: 01625510
- Web: www.aligntech.com
Capitalization:- Market Cap: $15.09556 billion
- Outstanding Shares: 80,150,000
Average Prices:- 50 Day Moving Avg: $176.23
- 200 Day Moving Avg: $145.25
- 52 Week Range: $83.27 - $190.04
P/E:- Trailing P/E Ratio: 64.10
- Foreward P/E Ratio: 45.43
- P/E Growth: 2.16
Sales & Book Value:- Annual Revenue: $1.24 billion
- Price / Sales: 12.10
- Book Value: $13.45 per share
- Price / Book: 13.92
Profitability:- EBIDTA: $306.55 million
- Net Margins: 19.18%
- Return on Equity: 23.87%
- Return on Assets: 16.93%
Debt:- Current Ratio: 2.36%
- Quick Ratio: 2.28%
Misc:- Average Volume: 909,734 shs.
- Beta: 1.55
- Short Ratio: 3.31
Frequently Asked Questions for Align Technology (NASDAQ:ALGN)
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Thursday, July, 27th. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.12. The company earned $356.50 million during the quarter, compared to analysts' expectations of $343.43 million. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. Align Technology's quarterly revenue was up 32.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.62 EPS. View Align Technology's Earnings History.
When will Align Technology make its next earnings announcement?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology updated its third quarter earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $0.79-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.79. The company issued revenue guidance of $355-360 million, compared to the consensus revenue estimate of $341.95 million.
Where is Align Technology's stock going? Where will Align Technology's stock price be in 2017?
10 equities research analysts have issued 1 year target prices for Align Technology's stock. Their forecasts range from $150.00 to $210.00. On average, they anticipate Align Technology's stock price to reach $185.00 in the next twelve months. View Analyst Ratings for Align Technology.
What are analysts saying about Align Technology stock?
Here are some recent quotes from research analysts about Align Technology stock:
- 1. According to Zacks Investment Research, "Align Technology’s second-quarter 2017 performance was promising with it beating the Zacks Consensus Estimate on both the fronts. We are encouraged by the company’s strong InvisAlign Technology prospects and growth in North America and international regions. Management particularly expects consistent growth in the Asia-Pacific region. To note, the company has recently opened a new InvisAlign Technology Treatment Planning facility in China. We are also upbeat about the multi-million dollar marketing campaign for promoting InvisAlign Technology brand. The company’s receipt of two U.S. patents for SmartTrack Aligner material buoys optimism. Notably, over the past one month, Align Technology has been trading above the industry. On the flip side, a strong dollar continues to act as a dampener. Also high consts and expenses weigh on margins. Moreover, tough competition and macroeconomic headwinds are other concerns." (8/21/2017)
- 2. Leerink Swann analysts commented, "healthy" (6/26/2017)
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), DENTSPLY SIRONA (XRAY), Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), DexCom (DXCM), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), NuVasive (NUVA), Neogen Corporation (NEOG), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH) and Inogen (INGN).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Charles Raymond Larkin Jr., Independent Chairman of the Board
- Joseph M. Hogan, President, Chief Executive Officer, Director
- John F. Morici, Chief Financial Officer
- Emory M. Wright, Vice President - Operations
- Roger E. George, Vice President - Corporate and Legal Affairs and General Counsel
- Simon Beard, Vice President, Managing Director - EMEA
- Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel
- Christopher C. Puco, Vice President, Managing Director - North America
- Julie Tay, Vice President, Managing Director - Asia Pacific
- Stuart Hockridge, Vice President - Global Human Resources
Who owns Align Technology stock?
Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.10%), BlackRock Inc. (5.96%), Polen Capital Management LLC (4.19%), State Street Corp (3.92%), Bank of New York Mellon Corp (2.37%) and Renaissance Technologies LLC (1.98%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David C Nagel, David L White, Emory Wright, George J Morrow, Greg J Santora, Jennifer Erfurth, Jennifer Olson, Joseph Lacob, Julie Tay, Raphael Pascaud, Roger E George, Sreelakshmi Kolli, Thomas M Prescott, Timothy A Mack, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.
Who sold Align Technology stock? Who is selling Align Technology stock?
Align Technology's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Ameriprise Financial Inc., Russell Investments Group Ltd., Alliancebernstein L.P., Bank of New York Mellon Corp, Principal Financial Group Inc., Fiera Capital Corp and Nationwide Fund Advisors. Company insiders that have sold Align Technology stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Jennifer Olson, Joseph Lacob, Sreelakshmi Kolli, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.
Who bought Align Technology stock? Who is buying Align Technology stock?
Align Technology's stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., State Street Corp, Federated Investors Inc. PA, Janus Henderson Group PLC, Voya Investment Management LLC, Victory Capital Management Inc., Old Mutual Global Investors UK Ltd. and Polen Capital Management LLC. View Insider Buying and Selling for Align Technology.
How do I buy Align Technology stock?
Shares of Align Technology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of Align Technology stock can currently be purchased for approximately $187.18.
MarketBeat Community Rating for Align Technology (NASDAQ ALGN)MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Align Technology (NASDAQ:ALGN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 10 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $185.00 (1.16% downside) |
Analysts' Ratings History for Align Technology (NASDAQ:ALGN)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/15/2017 | Goldman Sachs Group, Inc. (The) | Boost Price Target | Buy | $185.00 -> $210.00 | Low |  |
| 9/12/2017 | Robert W. Baird | Reiterated Rating | Buy | | Medium | |
| 9/11/2017 | Piper Jaffray Companies | Reiterated Rating | Buy | $200.00 | Medium | |
| 8/7/2017 | Stifel Nicolaus | Reiterated Rating | Buy | $200.00 -> $205.00 | Low | |
| 7/28/2017 | Leerink Swann | Reiterated Rating | Outperform | $194.00 -> $199.00 | Low | |
| 7/28/2017 | Bank of America Corporation | Upgrade | Neutral -> Buy | $175.00 -> $193.00 | High | |
| 7/17/2017 | Morgan Stanley | Reiterated Rating | Overweight | $175.00 -> $182.00 | Low | |
| 7/13/2017 | Credit Suisse Group | Reiterated Rating | Outperform | $140.00 -> $170.00 | Low | |
| 6/21/2017 | Northcoast Research | Reiterated Rating | Buy | $164.00 -> $186.00 | Low | |
| 6/1/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $150.00 | Low | |
| 3/24/2016 | Canaccord Genuity | Reiterated Rating | Buy | $72.00 -> $80.00 | N/A | |
| 3/23/2016 | Roth Capital | Boost Price Target | Buy | $72.00 -> $80.00 | N/A | |
| 1/29/2016 | William Blair | Reiterated Rating | Buy | | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for Align Technology (NASDAQ:ALGN)Earnings History by Quarter for Align Technology (NASDAQ ALGN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/26/2017 | | $0.79 | | | | | N/A | |
| 7/27/2017 | Q2 2017 | $0.73 | $0.85 | $343.43 million | $356.50 million | View | N/A | |
| 4/27/2017 | Q1 2017 | $0.67 | $0.85 | $297.46 million | $310.34 million | View | N/A | |
| 1/31/2017 | Q416 | $0.66 | $0.59 | $292.75 million | $293.20 million | View | N/A | |
| 11/7/2016 | Q3 | $0.52 | $0.63 | $271.61 million | $278.60 million | View | Listen | |
| 7/28/2016 | Q2 | $0.48 | $0.62 | $259.29 million | $269.40 million | View | Listen | |
| 4/28/2016 | Q116 | $0.40 | $0.50 | $236.22 million | $238.70 million | View | Listen | |
| 1/28/2016 | Q415 | $0.52 | $0.60 | $226.68 million | $230.30 million | View | Listen | |
| 10/22/2015 | Q315 | $0.34 | $0.34 | $205.10 million | $207.64 million | View | Listen | |
| 7/23/2015 | Q215 | $0.37 | $0.39 | $209.14 million | $209.50 million | View | Listen | |
| 4/23/2015 | Q115 | $0.32 | $0.38 | $190.89 million | $198.10 million | View | N/A | |
| 1/29/2015 | Q414 | $0.49 | $0.48 | $198.10 million | $198.60 million | View | N/A | |
| 10/23/2014 | Q314 | $0.43 | $0.47 | $188.70 million | $189.90 million | View | Listen | |
| 7/24/2014 | Q214 | $0.39 | $0.43 | $185.80 million | $192.53 million | View | N/A | |
| 4/23/2014 | Q114 | $0.35 | $0.39 | $177.57 million | $180.60 million | View | N/A | |
| 1/31/2014 | Q413 | $0.43 | $0.51 | $172.24 million | $178.30 million | View | N/A | |
| 10/17/2013 | Q313 | $0.30 | $0.42 | $158.64 million | $164.50 million | View | N/A | |
| 7/18/2013 | Q2 2013 | $0.28 | $0.36 | $156.13 million | $163.80 million | View | N/A | |
| 4/18/2013 | Q1 2013 | $0.23 | $0.26 | $149.40 million | $153.60 million | View | N/A | |
| 1/30/2013 | Q4 2012 | $0.22 | $0.27 | $134.75 million | $142.80 million | View | N/A | |
| 10/17/2012 | | $0.29 | $0.28 | | | View | N/A | |
| 7/19/2012 | | $0.28 | $0.34 | | | View | N/A | |
| 4/23/2012 | | $0.21 | $0.27 | | | View | N/A | |
| 1/30/2012 | | $0.21 | $0.28 | | | View | N/A | |
| 10/27/2011 | | $0.19 | $0.27 | | | View | N/A | |
| 8/1/2011 | | $0.20 | $0.20 | | | View | N/A | |
| 4/20/2011 | | $0.17 | $0.21 | | | View | N/A | |
| 1/26/2011 | | $0.17 | $0.14 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Align Technology (NASDAQ:ALGN)2017 EPS Consensus Estimate: $3.06
2018 EPS Consensus Estimate: $4.13
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 5 | $0.65 | $0.70 | $0.67 |
| Q2 2017 | 5 | $0.62 | $0.76 | $0.71 |
| Q3 2017 | 5 | $0.73 | $0.82 | $0.79 |
| Q4 2017 | 5 | $0.85 | $0.93 | $0.90 |
| Q1 2018 | 4 | $0.82 | $0.95 | $0.88 |
| Q2 2018 | 4 | $0.99 | $1.09 | $1.04 |
| Q3 2018 | 4 | $0.99 | $1.12 | $1.08 |
| Q4 2018 | 4 | $1.04 | $1.22 | $1.13 |
(Data provided by Zacks Investment Research)
Dividend History for Align Technology (NASDAQ:ALGN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Align Technology (NASDAQ:ALGN)Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 81.57%
Insider Trades by Quarter for Align Technology (NASDAQ:ALGN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/31/2017 | Joseph Lacob | Director | Sell | 50,000 | $144.98 | $7,249,000.00 | |
| 5/30/2017 | Joseph Lacob | Director | Sell | 3,874 | $143.96 | $557,701.04 | |
| 5/30/2017 | Sreelakshmi Kolli | VP | Sell | 1,000 | $144.00 | $144,000.00 | |
| 2/28/2017 | Joseph Lacob | Director | Sell | 50,000 | $102.67 | $5,133,500.00 | |
| 2/24/2017 | Christopher C Puco | VP | Sell | 24,353 | $101.88 | $2,481,083.64 | |
| 2/22/2017 | Thomas M Prescott | Director | Sell | 66,528 | $101.12 | $6,727,311.36 | |
| 2/15/2017 | Andrea Lynn Saia | Director | Sell | 4,000 | $99.68 | $398,720.00 | |
| 2/3/2017 | C Raymond Larkin Jr | Director | Sell | 15,000 | $94.71 | $1,420,650.00 | |
| 11/29/2016 | Jennifer Olson | VP | Sell | 3,662 | $95.44 | $349,501.28 | |
| 11/29/2016 | Warren S Thaler | Director | Sell | 8,500 | $95.57 | $812,345.00 | |
| 11/18/2016 | David L White | CFO | Sell | 11,152 | $95.53 | $1,065,350.56 | |
| 11/14/2016 | Thomas M Prescott | Director | Sell | 33,125 | $90.60 | $3,001,125.00 | |
| 8/29/2016 | Jennifer Olson | VP | Sell | 799 | $93.30 | $74,546.70 | |
| 8/15/2016 | Zelko Relic | VP | Sell | 13,577 | $95.91 | $1,302,170.07 | |
| 8/9/2016 | Julie Tay | VP | Sell | 3,000 | $92.60 | $277,800.00 | |
| 5/23/2016 | George J Morrow | Director | Sell | 50,000 | $77.72 | $3,886,000.00 | |
| 5/16/2016 | Raphael Pascaud | VP | Sell | 3,000 | $77.00 | $231,000.00 | |
| 5/10/2016 | Julie Tay | VP | Sell | 1,250 | $77.00 | $96,250.00 | |
| 5/5/2016 | C Raymond Larkin Jr | Director | Sell | 15,000 | $74.36 | $1,115,400.00 | |
| 5/5/2016 | Roger E George | VP | Sell | 27,311 | $75.00 | $2,048,325.00 | |
| 5/3/2016 | Julie Tay | VP | Sell | 1,754 | $75.00 | $131,550.00 | |
| 5/3/2016 | Thomas M Prescott | Director | Sell | 64,773 | $74.54 | $4,828,179.42 | |
| 2/25/2016 | Christopher C Puco | VP | Sell | 11,413 | $63.51 | $724,839.63 | |
| 2/23/2016 | Timothy A. Mack | VP | Sell | 28,384 | $63.25 | $1,795,288.00 | |
| 2/22/2016 | Christopher C. Puco | VP | Sell | 6,278 | $64.01 | $401,854.78 | |
| 2/4/2016 | Greg J Santora | Director | Sell | 9,000 | $67.28 | $605,520.00 | |
| 1/5/2016 | David C Nagel | Director | Sell | 1,100 | $64.64 | $71,104.00 | |
| 12/14/2015 | David C Nagel | Director | Sell | 1,100 | $65.20 | $71,720.00 | |
| 11/2/2015 | Julie Tay | VP | Sell | 1,500 | $66.67 | $100,005.00 | |
| 10/30/2015 | Emory Wright | VP | Sell | 25,272 | $65.04 | $1,643,690.88 | |
| 10/28/2015 | Jennifer Erfurth | VP | Sell | 6,198 | $66.04 | $409,315.92 | |
| 10/27/2015 | David L. White | CFO | Sell | 8,426 | $66.85 | $563,278.10 | |
| 10/27/2015 | Greg J. Santora | Director | Sell | 20,000 | $66.95 | $1,339,000.00 | |
| 8/25/2015 | Andrea Lynn Saia | Director | Sell | 3,567 | $55.10 | $196,541.70 | |
| 8/20/2015 | Warren S. Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | |
| 8/17/2015 | Thomas M Prescott | Director | Sell | 40,000 | $60.50 | $2,420,000.00 | |
| 5/15/2015 | Jennifer Erfurth | VP | Sell | 2,400 | $59.27 | $142,248.00 | |
| 5/7/2015 | C Raymond Larkin Jr | Director | Sell | 15,000 | $59.03 | $885,450.00 | |
| 5/6/2015 | Warren S Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | |
| 5/5/2015 | David L White | CFO | Sell | 1,899 | $59.37 | $112,743.63 | |
| 5/5/2015 | John Patrick Graham | CMO | Sell | 1,139 | $60.37 | $68,761.43 | |
| 5/5/2015 | Timothy A Mack | VP | Sell | 28,280 | $59.47 | $1,681,811.60 | |
| 5/1/2015 | Roger E George | VP | Sell | 23,248 | $58.69 | $1,364,425.12 | |
| 2/26/2015 | Raphael Pascaud | VP | Sell | 6,500 | $56.40 | $366,600.00 | |
| 2/24/2015 | Christopher C Puco | VP | Sell | 11,982 | $56.40 | $675,784.80 | |
| 11/4/2014 | Timothy A Mack | VP | Sell | 9,375 | $52.17 | $489,093.75 | |
| 10/28/2014 | C Raymond Larkin Jr | Director | Sell | 15,000 | $51.54 | $773,100.00 | |
| 10/28/2014 | Jennifer Erfurth | VP | Sell | 6,242 | $52.25 | $326,144.50 | |
| 8/27/2014 | Roger E George | VP | Sell | 10,875 | $55.85 | $607,368.75 | |
| 8/21/2014 | David L White | CFO | Sell | 4,600 | $54.42 | $250,332.00 | |
| 8/21/2014 | John Patrick Graham | CMO | Sell | 7,046 | $54.41 | $383,372.86 | |
| 8/19/2014 | Thomas M Prescott | CEO | Sell | 14,896 | $55.07 | $820,322.72 | |
| 5/29/2014 | Timothy A Mack | VP | Sell | 16,333 | $55.06 | $899,294.98 | |
| 5/1/2014 | Raphael Pascaud | VP | Sell | 2,000 | $50.79 | $101,580.00 | |
| 2/25/2014 | Christopher Puco | VP | Sell | 4,462 | $54.09 | $241,349.58 | |
| 2/24/2014 | Roger George | VP | Sell | 19,474 | $54.23 | $1,056,075.02 | |
| 2/11/2014 | Jennifer Erfurth | VP | Sell | 3,144 | $55.34 | $173,988.96 | |
| 2/7/2014 | Thomas Prescott | CEO | Sell | 236,979 | $54.64 | $12,948,532.56 | |
| 2/4/2014 | Timothy Mack | VP | Sell | 12,761 | $54.73 | $698,409.53 | |
| 2/4/2014 | Warren Thaler | Director | Sell | 18,000 | $54.75 | $985,500.00 | |
| 10/31/2013 | Jennifer Erfurth | VP | Sell | 3,242 | $56.97 | $184,696.74 | |
| 10/30/2013 | Richard M.L. Twomey | VP | Sell | 4,010 | $57.05 | $228,770.50 | |
| 10/30/2013 | Thomas M Prescott | CEO | Sell | 188,176 | $56.88 | $10,703,450.88 | |
| 10/30/2013 | Warren S Thaler | Director | Sell | 35,250 | $56.55 | $1,993,387.50 | |
| 10/22/2013 | George J Morrow | Director | Sell | 75,000 | $57.27 | $4,295,250.00 | |
| 10/22/2013 | Thomas M Prescott | CEO | Sell | 74,513 | $58.00 | $4,321,754.00 | |
| 8/29/2013 | Richard M.L. Twomey | VP | Sell | 2,135 | $43.76 | $93,427.60 | |
| 8/29/2013 | Timothy Mack | SVP | Sell | 18,477 | $43.32 | $800,423.64 | |
| 8/9/2013 | Joseph Lacob | Director | Sell | 8,000 | $43.85 | $350,800.00 | |
| 8/1/2013 | Greg Santora | Director | Sell | 16,000 | $43.79 | $700,640.00 | |
| 7/30/2013 | Warren S Thaler | Director | Sell | 10,000 | $42.24 | $422,400.00 | |
| 7/25/2013 | Roger E George | VP | Sell | 26,252 | $43.55 | $1,143,274.60 | |
| 7/24/2013 | Richard M.L. Twomey | VP | Sell | 4,532 | $43.42 | $196,779.44 | |
| 5/31/2013 | Joseph Lacob | Director | Sell | 49,998 | $36.16 | $1,807,927.68 | |
| 5/15/2013 | Richard M.L. Twomey | VP | Sell | 1,875 | $36.10 | $67,687.50 | |
| 2/4/2013 | Len Hedge | SVP | Sell | 100,000 | $31.38 | $3,138,000.00 | |
| 11/12/2012 | Dan Scott Ellis | VP | Sell | 18,815 | $26.52 | $498,973.80 | |
| 8/9/2012 | Joseph Lacob | Director | Sell | 300,000 | $34.97 | $10,491,000.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Align Technology (NASDAQ:ALGN)
Latest Headlines for Align Technology (NASDAQ:ALGN)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to Align Technology, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 8:47 PM |
| 5 Top-Performing Stocks Driving S&P 500 ETF Higher
finance.yahoo.com - September 18 at 4:07 PM |
 | Align Technology, Inc. (ALGN) Expected to Post Quarterly Sales of $358.40 Million
www.americanbankingnews.com - September 16 at 3:30 AM |
| Align Technology, Inc. (ALGN) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - September 16 at 2:46 AM |
| Align Technology, Inc. (ALGN) Price Target Increased to $210.00 by Analysts at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - September 15 at 11:46 AM |
| 3D Printing Moves Align Technology Toward $1.3 Billion In Sales
finance.yahoo.com - September 14 at 4:19 PM |
 | ALGN Crosses Above Average Analyst Target - Nasdaq.com - Nasdaq
www.nasdaq.com - September 13 at 9:54 PM |
| Equities Analysts Offer Predictions for Align Technology, Inc.'s Q1 2018 Earnings (ALGN)
www.americanbankingnews.com - September 13 at 10:14 AM |
| Align Technology, Inc. (ALGN) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - September 12 at 9:28 PM |
| Align Technology Introduces a New Brand Identity for the iTero(R) Scanning System and Tools
finance.yahoo.com - September 12 at 3:57 PM |
| Align Technology, Inc. (ALGN) Earns "Buy" Rating from Piper Jaffray Companies
www.americanbankingnews.com - September 12 at 12:08 AM |
| January 2020 Options Now Available For Align Technology (ALGN)
www.nasdaq.com - September 11 at 4:35 PM |
| ETFs with exposure to Align Technology, Inc. : September 9, 2017
finance.yahoo.com - September 9 at 2:08 AM |
| Align Technology, Inc. :ALGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017
finance.yahoo.com - September 7 at 3:43 PM |
| Align Technology at 52-Week High: What's Driving the Stock? - Nasdaq
www.nasdaq.com - September 6 at 3:40 PM |
| Align Technology at 52-Week High: What's Driving the Stock?
finance.yahoo.com - September 6 at 3:40 PM |
 | Align Technology, Inc. (ALGN): Up More Than 85% and Still Smiling - Investorplace.com
investorplace.com - September 1 at 9:18 PM |
| BioScrip's Infusion Business Strong, Dull 2017 View a Drag (Revised)
finance.yahoo.com - September 1 at 4:17 PM |
| Align Technology, Inc. (ALGN): Up More Than 85% and Still Smiling
investorplace.com - September 1 at 11:57 AM |
| Zacks: Brokerages Expect Align Technology, Inc. (ALGN) Will Post Quarterly Sales of $358.40 Million
www.americanbankingnews.com - August 29 at 11:44 AM |
| Head to Head Survey: DENTSPLY SIRONA (XRAY) versus Align Technology (ALGN)
www.americanbankingnews.com - August 28 at 8:10 PM |
| Zacks: Analysts Expect Align Technology, Inc. (ALGN) Will Announce Earnings of $0.81 Per Share
www.americanbankingnews.com - August 27 at 6:16 AM |
| Thursday Sector Leaders: Healthcare, Services - Nasdaq
www.nasdaq.com - August 24 at 3:44 PM |
 | Patterson Dental and Align Technology Announce Distribution Agreement for the iTero® Element Intraoral Scanning ... - Business Wire (press release)
www.businesswire.com - August 24 at 3:44 PM |
| Align Technology-Patterson Dental Deal Expands iTero Reach - Nasdaq
www.nasdaq.com - August 24 at 3:44 PM |
| Align Technology-Patterson Dental Deal Expands iTero Reach
finance.yahoo.com - August 24 at 3:44 PM |
| Patterson Dental and Align Technology Announce Distribution Agreement for the iTero® Element Intraoral Scanning System
finance.yahoo.com - August 23 at 8:57 PM |
 | Align Technology's Invisalign Sales Strong Amid Margin Woes
www.zacks.com - August 22 at 4:32 PM |
| Align Technology, Inc. (ALGN) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - August 22 at 2:32 AM |
| BioScrip's Infusion Business Strong, Dull 2017 View a Drag
finance.yahoo.com - August 21 at 3:55 PM |
| Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio
finance.yahoo.com - August 21 at 3:55 PM |
| Zacks Investment Research Lowers Align Technology, Inc. (ALGN) to Hold
www.americanbankingnews.com - August 21 at 10:12 AM |
| FY2019 EPS Estimates for Align Technology, Inc. (ALGN) Lifted by Analyst
www.americanbankingnews.com - August 21 at 9:40 AM |
| Walgreens Boots to Gain From Altered Rite Aid Deal, Alliance - Nasdaq
www.nasdaq.com - August 18 at 3:54 PM |
| Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics ... - Nasdaq
www.nasdaq.com - August 18 at 3:54 PM |
| Allscripts, Elligo Health Enter in Strategic Partnership - Nasdaq
www.nasdaq.com - August 18 at 3:54 PM |
| Myriad Genetics' EndoPredict Gets Positive Coverage Decision - Nasdaq
www.nasdaq.com - August 18 at 3:54 PM |
| Zimmer (ZBH) Plagued by Various Internal and External Issues - Nasdaq
www.nasdaq.com - August 18 at 3:54 PM |
 | Stock Exchange: Is The Bull Market Slowing? - Seeking Alpha
seekingalpha.com - August 18 at 3:54 PM |
| Allscripts, Elligo Health Enter in Strategic Partnership
finance.yahoo.com - August 18 at 3:54 PM |
| Fluidigm (FLDM) Licenses CFTR Assay From Baylor Genetics
finance.yahoo.com - August 18 at 3:54 PM |
| Walgreens Boots to Gain From Altered Rite Aid Deal, Alliance
finance.yahoo.com - August 18 at 3:54 PM |
| Myriad Genetics' EndoPredict Gets Positive Coverage Decision
finance.yahoo.com - August 18 at 3:54 PM |
| Zimmer (ZBH) Plagued by Various Internal and External Issues
finance.yahoo.com - August 18 at 3:53 PM |
| Omnicell Upgrades Web Portal, Grows in Medication Management - Nasdaq
www.nasdaq.com - August 18 at 3:15 AM |
| Walgreens' (WBA) Research Website to Add Value in Healthcare - Nasdaq
www.nasdaq.com - August 18 at 3:15 AM |
| Noteworthy Thursday Option Activity: ALGN, CELG, CB - Nasdaq
www.nasdaq.com - August 17 at 10:15 PM |
| Here's Why Investors Should Buy Edwards Lifesciences Now - Nasdaq
www.nasdaq.com - August 17 at 10:15 PM |
| Henry Schein to Offer CAEK's HIPAA Software LayerCompliance - Nasdaq
www.nasdaq.com - August 17 at 10:14 PM |
| Here's Why Investors Should Buy Align Technology (ALGN) Now - Yahoo News
finance.yahoo.com - August 17 at 10:14 PM |
Align Technology (ALGN) Chart for Wednesday, September, 20, 2017
